Pryanka Thakur | Dengue | Young Scientist Award

Published on by Cell Biologist

Dr. Pryanka Thakur | Dengue | Young Scientist Award

Dr. Pryanka Thakur | Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh | India

Dr. Pryanka Thakur is a dedicated virologist and Project Research Scientist-I at PGIMER, Chandigarh, working in Professor Sunil Sethi’s laboratory. She earned her Ph.D. in Virology from PGIMER under the mentorship of Professor (Dr.) Radha Kanta Ratho, Dean of PGIMER. Her research revolves around molecular pathogenesis, particularly focusing on viral diseases such as Dengue, COVID-19, Hepatitis E, and emerging zoonotic threats. With numerous high-impact publications and presentations at national and international forums, Dr. Thakur has built a commendable academic and research portfolio. Her work contributes to a deeper understanding of viral mechanisms and their public health implications. She has received accolades like the Young Scientist Award and DST-SERB travel grant, reflecting her potential as a rising star in infectious disease research. Passionate about molecular diagnostics and disease pathogenesis, Dr. Thakur’s academic rigor and commitment position her as a promising candidate for the Research for Young Scientist Award.

Publication Profile: 

Orcid

Scopus

Education:

Dr. Pryanka Thakur completed her Ph.D. in Virology at the prestigious Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, from August 2018 to March 2024. Her thesis, titled “Role of inflammasome and autophagy in the pathogenesis of severity of Dengue fever,” was conducted under the supervision of Professor (Dr.) Radha Kanta Ratho, a leading authority in virology. Her doctoral work explored critical host-pathogen interactions, offering insights into mechanisms influencing disease severity. During this period, she honed her skills in molecular virology, diagnostics, and cellular biology. Her academic foundation is deeply rooted in translational and clinical virology, with particular emphasis on autophagy, inflammasomes, and immunological responses during viral infections. Through her rigorous training and extensive hands-on experience with cutting-edge lab techniques, she emerged as a well-rounded scientist with both technical expertise and conceptual depth in infectious disease research, specifically RNA viruses and M. tuberculosis.

Experience:

Dr. Pryanka Thakur currently serves as a Project Research Scientist-I in the Department of Medical Microbiology, PGIMER, Chandigarh, under the mentorship of Professor Sunil Sethi. Her research has primarily focused on virological and immunological responses to emerging and re-emerging infections. She has extensive experience in molecular biology, cell culture, diagnostics, and bioinformatics, contributing to major national and international research initiatives. During her Ph.D., she contributed significantly to studies on Dengue pathogenesis, SARS-CoV-2 evolution, and the intersection of autophagy and inflammasome activity. Her experience also includes collaboration with clinicians, epidemiologists, and diagnostic labs, showcasing her ability to work in interdisciplinary settings. Beyond lab work, she has actively participated in scientific writing, mentoring junior researchers, and presenting findings at forums like ECCMID and VIROCON. Her track record reflects a strong combination of leadership, innovation, and research integrity—making her a standout young investigator.

Awards and Honors:

Dr. Pryanka Thakur’s excellence in research has been recognized through prestigious accolades. In 2024, she was honored with the Young Scientist Award at the VIROCON 2024 conference held at DRDE, Gwalior, for her impactful Ph.D. research on Dengue virus pathogenesis. Additionally, she secured the highly competitive DST-SERB International Travel Grant to present her work at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark. These honors are a testament to the significance and quality of her research in infectious diseases. Her recognition on both national and international platforms demonstrates her rising reputation within the scientific community. These awards not only validate her current achievements but also underscore her potential for future contributions to global health challenges. Her work continues to resonate with experts in virology, public health, and molecular diagnostics—solidifying her status as a promising candidate for further research awards.

Research Focus:

Dr. Pryanka Thakur’s research is rooted in the pathogenesis, immunology, and molecular biology of emerging infectious diseases. Her Ph.D. research dissected the intricate roles of inflammasome activation and autophagy dysregulation in severe Dengue infections—paving the way for targeted therapies and better clinical outcomes. She also actively investigates RNA viruses, including SARS-CoV-2, Hepatitis E, Monkeypox, Nipah, and avian influenza, exploring their mutation patterns, immune evasion strategies, and pandemic potential. Her recent studies also delve into co-infections (e.g., Dengue and COVID-19 in pregnancy), and the reemergence of known pathogens in the post-pandemic era. Dr. Thakur maintains a special interest in molecular diagnostics, enabling early and accurate disease detection. Her contributions bridge laboratory science with clinical relevance, aiming to develop diagnostic tools and deepen our understanding of host-pathogen dynamics. This interdisciplinary approach positions her to make substantial contributions to the field of translational virology and public health microbiology.

Publications Top Notes: 

  1. Waves and variants of SARS-CoV-2: Understanding the causes and effect of the COVID-19 catastrophe – Infection, 2022.

  2. Viral Hepatitis E and Chronicity: A growing public health concern – Frontiers in Microbiology, 2020.

  3. Monkeypox virus in humans: A concern – Trespassing global boundaries – Int J Surg, 2022.

  4. Emergence of novel omicron hybrid variants: BA(x), XE, XD, XF – More than just alphabets – Int J Surg, 2022.

  5. Nipah Outbreak: Beginning of another pandemic in the era of COVID-19 and Zika? – Brain Behav Immun, 2021.

  6. Evolutionary dynamics of emergent SARS-CoV-2 variants: Just within a year – Immunome Research, 2021.

  7. Avian influenza revisited: Concerns and constraints – VirusDisease, 2022.

  8. Maternal and perinatal outcome in Dengue and COVID-19 co-infected pregnancies – Eur J Obstet Gynecol Reprod Biol, 2023.

  9. Post-COVID-19 era: Re-emergence of known and future (X) viral pathogens – Vacunas, 2024.

  10.  Paclitaxel production from endophytic Mucor circinelloides from Himalayan Taxus sp. – 3 Biotech, 2024.

Conclusion:

In conclusion, Dr. Pryanka Thakur is an exceptionally well-qualified candidate for the Research for Young Scientist Award. Her academic rigor, publication excellence, and strong interest in infectious disease pathogenesis make her a standout young researcher. She brings a unique blend of molecular insights and public health relevance to her work, making significant contributions to understanding emerging viral threats. With national recognition and international exposure already under her belt, she is on a clear upward trajectory in academic science. Supporting her at this stage through the Young Scientist Award would not only validate her past contributions but also empower her to lead future advancements in virology, diagnostics, and translational medical research. With minor enhancements in project independence and translational focus, Dr. Thakur is poised to become a future leader in infectious disease research, making her a deserving recipient of this award.

 

Maria Andriolo | Host-Pathogen Interactions | Best Innovation Award

Published on by Cell Biologist

Dr. Maria Andriolo | Host-Pathogen Interactions | Best Innovation Award

Dr. Maria Andriolo, ASP CALTANISSETTA, Italy

Maria Andriolo is a dedicated biomedical researcher and clinical biologist with extensive experience in neuroscience, immunology, and post-traumatic disorders. Her multidisciplinary approach has led to impactful contributions in clinical diagnostics, neurorehabilitation, and infectious disease studies. With decades of experience across leading Italian institutions, she combines clinical insight with scientific rigor. She has served in prestigious roles such as a Member of the State Examination Commission and President of Public Selection Committees. Dr. Andriolo is widely published, collaborating on pioneering studies in fields including brain trauma, sepsis diagnostics, and vaccine immunoresponse. Known for her collaborative spirit and leadership, she also contributes as a conference moderator and educator. Her body of work reflects a deep commitment to translational science that benefits patient care and public health.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. Multidisciplinary Research Impact
    Dr. Andriolo’s work spans key medical research areas including:

    • Neurology (e.g., traumatic brain injury, disorders of consciousness)

    • Clinical Biochemistry (e.g., neuron-specific enolase, BDNF, CSF biomarkers)

    • Microbiology & Infectious Diseases (e.g., antimicrobial resistance, sepsis diagnostics)

    • Immunology & Vaccine Response (e.g., post-COVID vaccine serology in healthcare workers)

  2. Innovation with Real-World Impact
    Her studies focus on biomarkers for rapid diagnosis, rehabilitation outcomes, and immune responses, directly translating into improved patient care, particularly in:

    • Post-traumatic brain disorders

    • Early detection of sepsis

    • Infection control strategies

  3. Collaborative and High-Impact Publications

    • Extensive peer-reviewed articles in PubMed-indexed journals like Journal of Neurotrauma, Brain Sciences, Vaccines, and Science Reports.

    • Publications show collaborations with leading national research teams and hospitals.

  4. Scientific Leadership & Recognition

    • Appointed as President of National Selection Committees and State Examiner for Biologist Certification.

    • Served as Moderator at ECM Conferences, further demonstrating peer trust and scientific communication skills.

⚠️ Areas for Improvement:

  1. Lead Authorship and Project Ownership

    • While her publication record is strong, she is mostly listed as co-author. Clear documentation of principal investigator roles, research grants led, or independent innovation patents would further bolster her candidacy.

  2. International Presence

    • A broader international profile (e.g., global conferences, cross-border collaborative studies, citations from non-EU entities) could elevate her global impact.

  3. Recent Innovation Highlights

    • A focused submission highlighting a single groundbreaking innovation (e.g., biomarker panel for TBI prognosis or rapid sepsis tool) would align more clearly with “Best Innovation” award criteria.

🎓 Education:

While the detailed educational background isn’t listed, Maria Andriolo’s professional and scientific achievements imply a robust academic foundation in Biology, Neuroscience, and Clinical Diagnostics, likely culminating in at least a Master’s or Doctorate-level education in Biomedical Sciences. Her involvement as a State Examiner for Biologist Qualification and leader of academic committees suggests a longstanding connection with university-level institutions, particularly the University of Messina. Given her expertise and publication record, it is evident she has received specialized training in neurobiology, molecular genetics, clinical chemistry, and medical microbiology. She has actively participated in ECM-accredited medical conferences, indicating a commitment to continuing professional development. This mix of structured education and applied training positions her as a highly qualified scientific professional.

💼 Professional Experience:

Maria Andriolo holds significant academic and clinical leadership roles. She was appointed in July 2024 as a Member of the State Examination Commission for Biologists at the University of Messina, overseeing professional certifications. In June 2023, she served as President of the Examination Committee for a public selection competition for C1 research staff. She is frequently invited to act as a moderator at ECM-accredited conferences, underscoring her peer recognition in the field. Her expertise spans biomedical research, academic evaluation, and public health diagnostics. Maria’s ability to combine scientific knowledge with regulatory oversight and teaching makes her a valuable contributor to academia and public institutions. Her leadership and participation in national scientific initiatives demonstrate her commitment to innovation, clinical application, and academic excellence.

🔬 Research Focus:

Maria Andriolo’s research is anchored in neuroscience, post-traumatic disorders, biomarkers, and infectious diseases. Her work often centers on patients with disorders of consciousness following trauma, analyzing biomarkers like BDNF, neurofilaments, and amyloid-beta proteins. She is a leading contributor in understanding the neurochemical pathways associated with brain injury and rehabilitation. Maria has also co-authored influential studies on sepsis diagnostics, immune response to COVID-19 vaccines, and antimicrobial resistance. Her research combines laboratory diagnostics with clinical applications, enabling faster diagnoses and more effective treatment strategies. She is known for utilizing multidisciplinary frameworks, involving neurologists, microbiologists, and clinicians to translate science into solutions. This strong translational impact underscores her candidacy for the Best Innovation Award, as she bridges the gap between research and patient-centered innovation.

📚 Publications Top Notes:

  1. 🧠 Reduced neuron-specific enolase levels in chronic severe traumatic brain injury

  2. 🧬 Multidisciplinary approach for the rapid diagnosis of sepsis

  3. 💉 Serological analysis of humoral immune response in Sicilian HCWs post-COVID vaccination

  4. 🧠 Dissociation of CSF amyloid-beta and tau in post-traumatic consciousness disorders

  5. 💉 Staphylococcus aureus in bloodstream infections: frequency & antimicrobial resistance

  6. 🧠 Serum BDNF levels are reduced in disorders of consciousness

  7. 🧠 Six-month outcomes in traumatic consciousness disorders (hemorrhagic/non-hemorrhagic)

  8. 🧠 BDNF Val66Met polymorphism and post-traumatic vegetative state recovery

  9. 💉 Anaphylaxis to streptomycin

  10. 🧠 Prolonged CSF neurofilament light chain increase in traumatic brain patients

🏁 Conclusion:

Maria Andriolo is a highly suitable and deserving candidate for the Research for Best Innovation Award. Her research demonstrates:

  • Exceptional depth in translational neuroscience and diagnostics

  • A strong commitment to multidisciplinary collaboration

  • A clear track record of innovation that impacts both patient outcomes and healthcare protocols

 

 

 

Elena-Roxana Matache (Vasilache) | Host-Pathogen Interactions | Best Researcher Award

Published on by Cell Biologist

Mrs. Elena-Roxana Matache (Vasilache) | Host-Pathogen Interactions | Best Researcher Award

Mrs. Elena-Roxana Matache (Vasilache), Dunarea de Jos University of Galati, Romania

Elena-Roxana Matache (Vasilache) is a dedicated Romanian researcher and academic with a strong background in pediatric infectious diseases, currently serving as a Doctoral Assistant at the Faculty of Medicine and Pharmacy, “Dunărea de Jos” University of Galați. Born on October 24, 1989, she has built a robust academic and research career focused on virology, respiratory infections, and antibiotic resistance in children. Elena is a passionate educator with qualifications in psychopedagogy and has actively contributed to both teaching and scientific research. She has published extensively in peer-reviewed journals, showcasing her commitment to advancing pediatric healthcare. Her collaboration in multidisciplinary teams has led to insightful studies on SARS-CoV-2, adenovirus infections, and digestive pathogens. Through her impactful research, Elena continues to play a crucial role in improving diagnostic and treatment strategies for pediatric patients. Her dedication and scientific contributions make her a strong candidate for the Best Researcher Award.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. Robust Research Output: Over 11 peer-reviewed publications across international journals like Viruses, Pediatric Pulmonology, and Technium BioChemMed, with significant contributions to pediatric infectious diseases.

  2. Focused Research Themes: Specializes in respiratory viral infections, SARS-CoV-2, antibiotic resistance, and gastrointestinal viruses in children—areas of major global health interest.

  3. Scientific Recognition: Recipient of First and Second Prizes at doctoral-level scientific conferences for research on SARS-CoV-2 and respiratory infections in children.

  4. Multidisciplinary Collaboration: Works with interdisciplinary teams combining clinical, epidemiological, and laboratory expertise—demonstrating strong teamwork and communication skills.

  5. Educational Contribution: Active academic involvement as a Doctoral Assistant since 2020, contributing to student training and curriculum development.

  6. Language Proficiency: Fluent in Romanian and Spanish at C1 level, enabling collaboration across linguistic boundaries.

⚙️ Areas for Improvement:

  1. International Exposure: While her publication record is strong, increasing international conference participation or fellowships would further raise her profile globally.

  2. Research Funding & Grants: Future applications for national or European research grants would solidify her independence and research leadership.

  3. Independent Lead Authorship: Expanding her role as first or corresponding author across high-impact publications would better establish her as a principal investigator.

  4. Innovation & Technology Use: Engaging in molecular diagnostics, AI in medicine, or public health informatics could diversify her impact and align with global research trends.

🎓 Education:

Elena-Roxana Matache completed her higher education at the “Dunărea de Jos” University of Galați, Romania. She earned certifications in psycho-pedagogical training programs, completing Level I in early 2021 under the Ministry of Health, and Level II in mid-2021 through the Ministry of Education. These qualifications reflect her commitment to both research and academic teaching. Her educational background combines medical expertise with pedagogy, equipping her with essential skills for both clinical instruction and scientific research. Elena’s multidisciplinary training has enabled her to pursue a doctoral path in the medical field, focusing on pediatric infectious diseases and public health. Her education emphasizes the importance of continuous professional development, and her role as a doctoral assistant underscores her capability to bridge scientific inquiry with clinical application and medical education. Her diverse academic background supports her ongoing contributions to the fields of pediatric medicine, microbiology, and virology.

🧪 Professional Experience:

Since October 2020, Elena-Roxana Matache has held the position of Doctoral Assistant at the Faculty of Medicine and Pharmacy, “Dunărea de Jos” University of Galați. In this academic role, she is involved in both teaching and research activities, focusing on pediatric medicine, infectious diseases, and virology. She collaborates with medical professionals and researchers in conducting clinical studies, publishing scientific papers, and mentoring students. Elena has co-authored numerous high-impact publications on viral respiratory infections, SARS-CoV-2, and antibiotic resistance in children. Her contributions to scientific conferences and academic events further illustrate her active engagement in the medical research community. Working in a university clinical setting, she bridges the gap between theoretical knowledge and practical application. Her hands-on experience with pediatric cases and laboratory analysis, combined with her strong academic foundation, positions her as a key contributor to child healthcare research in Romania.

🏅 Awards and Honors:

Elena-Roxana Matache has received significant recognition for her scientific work through academic awards and honors. She was awarded First Prize at the 10th edition of the Scientific Conference of the Doctoral School “CSSD” (June 2022) for her research on RT-PCR cycle threshold analysis in children with SARS-CoV-2. In June 2025, she won the Second Prize at the 13th edition of the same conference for her clinical profile research on respiratory infections in children under two years of age. Her impactful work in pediatric virology and epidemiology continues to receive acknowledgment from academic institutions and peer researchers. Elena’s awards underscore her methodical research approach and commitment to addressing real-world health challenges through scientific investigation. These honors demonstrate her ongoing contribution to pediatric health and infectious disease management, affirming her status as a high-performing researcher and educator with substantial academic potential.

🔬 Research Focus:

Elena-Roxana Matache’s research primarily focuses on pediatric infectious diseases, with a special emphasis on viral respiratory infections, gastrointestinal pathogens, SARS-CoV-2, and antibiotic resistance in children. Her investigations include the epidemiology, diagnosis, and clinical management of infections caused by adenovirus, rotavirus, norovirus, and Klebsiella pneumoniae. Her work has also addressed immune markers like IgA and IgG in the diagnosis of celiac disease, and she has contributed significantly to understanding COVID-19 impacts in pediatric and pregnant populations. Elena is interested in translational medicine, connecting clinical findings with laboratory data to improve diagnostic tools and public health interventions. Her multidisciplinary research involves collaboration with clinicians, microbiologists, and epidemiologists, leading to evidence-based solutions for pediatric care. Through her publications and conference presentations, she has contributed valuable insights to global discussions on child health, making her an active and impactful researcher in the medical field.

📚 Publications Top Notes: 

  1. 🦠 Pathogen Profile of Children Hospitalised with Viral Respiratory Infections in Galati County, Romania – Viruses, 2025

  2. 🧬 Prevalence of Respiratory Tract Infections With Adenovirus in Children – Pediatric Pulmonology, 2025

  3. 🧫 The Role of IgA and IgG Anti-Transglutaminase Antibodies in the Diagnosis of Celiac Disease in Children – Technium BioChemMed, 2023

  4. 💊 Aspects of Antibiotic Resistance for Klebsiella Pneumoniae in a Children Hospital – Innovative Romanian Food Biotechnology, 2023

  5. 🚼 Antibiotic Resistance in Urinary Tract Infection in Children – Technium BioChemMed, 2022

  6. 🧻 Digestive Infections with Norovirus, Rotavirus and Adenovirus in Children from Galati County – Romanian Journal of Laboratory Medicine, 2022

  7. 🤰 Current Aspects in the Management of SARS-CoV-2 Infection in Pregnancy – Economics and Applied Informatics, 2022

  8. 🧪 The Management of Adenovirus Infection in the Children’s Hospital from Galati – Economics and Applied Informatics, 2022

  9. 🧍‍♂️ Seroprevalence of SARS-CoV-2 Infection in Adults in Galati Area – Annals of Dunarea de Jos University Galati, Medicine, 2020

  10. 🧠 Neurological Affections Impact in Geriatrics – Annals of Dunarea de Jos University Galati, Medicine, 2020

🧾 Conclusion:

Elena-Roxana Matache demonstrates all the essential qualities of a high-potential early-career researcher—scientific productivity, topical expertise, and a clear focus on impactful pediatric health issues. Her publications, awards, and active engagement in academic and clinical research make her a strong and deserving candidate for the Best Researcher Award.

Jean Bosco MBONIMPA | Malaria Disease | Best Academic Researcher Award

Published on by Cell Biologist

Mr. Jean Bosco MBONIMPA | Malaria Disease | Best Academic Researcher Award

Mr. Jean Bosco MBONIMPA, King Faisal Hospital, Rwanda

Jean Bosco Mbonimpa is a Rwandan biomedical laboratory scientist and emerging molecular biology researcher based in Kigali. With over a decade of experience in clinical diagnostics, molecular tools development, and infectious disease surveillance, Jean Bosco has contributed significantly to public health through his work on HIV and malaria research projects. Currently serving as the Laboratory Quality Officer at King Faisal Hospital Rwanda, he is committed to maintaining high standards in laboratory quality management systems. He holds a BSc in Biomedical Laboratory Sciences and is pursuing an MSc in Biotechnology at the University of Rwanda. Jean Bosco is known for his meticulous attention to GCLP and QA/QC practices, and he is a published author in the International Journal of Molecular Sciences. His contributions include developing molecular tools using MSP2 polymorphism for malaria prediction and analyzing cytokine profiles to understand clinical presentations of malaria. His work embodies the fusion of laboratory excellence and impactful research.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Robust Technical Expertise:
    Jean Bosco demonstrates strong hands-on experience in clinical diagnostics, molecular biology, and public health research. His skill set spans DNA/RNA extraction, PCR, serology, and QA/QC—critical for high-impact biomedical research.

  2. High-Impact Research Publications:
    His co-authorship of two peer-reviewed publications in the International Journal of Molecular Sciences shows meaningful contributions to cutting-edge malaria research, particularly in molecular tool development and immunological profiling.

  3. Commitment to Quality Standards:
    His current role as Laboratory Quality Officer at King Faisal Hospital, combined with his consistent application of GCLP and ISO standards, highlights his dedication to maintaining rigorous laboratory practices.

  4. Academic Progression and Initiative:
    As part of the first cohort pursuing an MSc in Biotechnology, he reflects academic ambition and a forward-looking research mindset, further strengthening his academic credibility.

  5. National Health Contribution:
    His active participation in large-scale national programs like RPHIA and malaria elimination projects underscores a direct impact on Rwanda’s public health systems.

⚙️ Areas for Improvement:

  1. Limited Diversity in Research Topics:
    While his malaria research is commendable, branching out into other infectious diseases, biotechnology innovations, or emerging pathogens could diversify his portfolio and enhance interdisciplinary relevance.

  2. Need for Broader Research Leadership Roles:
    Most of his published work positions him as a co-author. Leading future research projects and acting as principal investigator would solidify his academic leadership.

  3. Visibility & International Collaboration:
    Participation in international conferences, workshops, and grant-funded collaborations would increase his global academic footprint and recognition.

  4. Capacity Building & Mentorship:
    Involvement in mentoring junior researchers or students would align with the award’s broader academic mission of knowledge dissemination and leadership development.

🎓 Education:

Jean Bosco Mbonimpa’s academic journey reflects a strong foundation in biomedical sciences and a progressive dive into advanced research. He earned his Bachelor of Science in Biomedical Laboratory Sciences from the University of Rwanda – College of Medicine and Health Sciences in 2013, a program that equipped him with essential clinical and diagnostic lab skills. Prior to that, he completed his A-Level education in Medical Laboratory Sciences at ESSA Ruhengeli, Musanze, in 2008. Currently, Jean Bosco is enrolled in the first cohort of the Master of Science in Biotechnology at the University of Rwanda – College of Science and Technology, where he is expanding his knowledge in molecular biology, bioinformatics, and translational research. His academic trajectory demonstrates both commitment to healthcare service delivery and a vision to innovate within biotechnology and infectious disease research. Through his studies, he has laid a strong theoretical and practical base for impactful biomedical innovations in Africa.

🧪 Experience:

Jean Bosco Mbonimpa brings over 10 years of hands-on laboratory experience in both clinical and research settings. Currently, he serves as a Laboratory Quality Officer at King Faisal Hospital Rwanda, where he oversees SOP development, audits, sterility testing, and QA documentation to ensure compliance with national and international standards. Previously, he contributed to various research initiatives including malaria efficacy studies and the Rwanda Population-based HIV Impact Assessment (RPHIA), where he conducted field-based blood sampling and diagnostic testing under strict GCLP protocols. His technical expertise covers parasitology, hematology, molecular diagnostics, and serology. His role in national and international research collaborations has made him a vital player in disease surveillance and laboratory quality assurance. Jean Bosco is not only a capable bench scientist but also an effective communicator and team collaborator, making him a valuable asset to both healthcare systems and research institutions focused on improving health outcomes.

🔬 Research Focus:

Jean Bosco Mbonimpa’s research centers on infectious disease diagnostics, with a particular focus on malaria and HIV. He is especially interested in harnessing molecular biology tools to better understand pathogen behavior and host responses. His recent work has explored the genetic diversity of Plasmodium falciparum, particularly using the polymorphism of the merozoite surface protein 2 (MSP2) to develop predictive tools for malaria episodes in endemic communities. Additionally, he has examined cytokine expression profiles in malaria patients, identifying selective upregulation patterns that could aid in clinical assessment and therapeutic interventions. Through rigorous GCLP-aligned procedures, Jean Bosco contributes to translational research efforts that bridge laboratory findings with real-world public health outcomes. His work is increasingly relevant in the global effort to eliminate malaria and better manage chronic infectious diseases through early diagnosis and molecular surveillance. With ongoing graduate studies, he is positioned to lead innovative health research in sub-Saharan Africa.

📚 Publications Top Notes:

  1. 🧬 Leveraging the Polymorphism of the Merozoite Surface Protein 2 (MSP2) to Engineer Molecular Tools for Predicting Malaria Episodes in a Community

  2. 🧫 Integrated Analysis of Cytokine Profiles in Malaria Patients Discloses Selective Upregulation of TGF-β1, β3, and IL-9 in Mild Clinical Presentation

🧾 Conclusion:

Jean Bosco Mbonimpa is a strong candidate for the Best Academic Researcher Award, especially in the domain of applied biomedical research and infectious disease diagnostics. His contributions to malaria research and laboratory quality assurance are both nationally impactful and globally relevant. While he would benefit from expanded research leadership and interdisciplinary engagement, his academic integrity, technical depth, and continuous professional development make him highly deserving of this recognition.

PANAGIOTA TSIATSIOU | Host-Pathogen Interactions | Best Researcher Award

Published on by Cell Biologist

Dr. PANAGIOTA TSIATSIOU | Host-Pathogen Interactions | Best Researcher Award

Dr. PANAGIOTA TSIATSIOU, AHEPA UNIVERSITY HOSPITAL, Greece

Dr. Panagiota Tsiatsiou is a dedicated medical biopathologist with over two decades of service in the Greek National Health System. Born on March 17, 1969, in Thessaloniki, Greece, she earned her M.D. from the Aristotle University of Thessaloniki and has specialized in hematology diagnostics, molecular biology, and public health. Since 2011, she has served in the Hematology Section at AHEPA University Hospital and was appointed Director in 2018. Her role extends beyond diagnostics to include leadership, training of residents, and managing lab operations, especially during the COVID-19 pandemic. With three Master’s degrees and active participation in scientific publications and conferences, Dr. Tsiatsiou continues to bridge clinical practice and research. Her work on angiopoietins and biomarkers in COVID-19 patients demonstrates her commitment to innovative healthcare solutions and translational medicine.

Publication Profile: 

Scopus

Orcid

✅ Strengths for the Award:

  1. Extensive Clinical and Laboratory Expertise
    Over 20 years of experience in microbiology and hematology laboratories, with advanced specialization in Medical Biopathology, PCR techniques, and molecular hematology.

  2. Research Impact in COVID-19
    Lead author in two recent international peer-reviewed publications (2024, 2025) on angiopoietins and endothelial damage in COVID-19—topics of significant relevance in post-pandemic biomedical research.

  3. Academic Qualifications
    Holder of three Master’s degrees in Health Services Management, Public Health, and Biomedical Sciences—demonstrating a strong interdisciplinary foundation and commitment to academic excellence.

  4. Mentorship and Leadership
    Director of the Hematology Section at AHEPA University Hospital since 2018; deeply involved in resident training and lab coordination, especially during the pandemic, proving strong leadership under crisis.

  5. Scientific Contribution

    • 6 publications (4 international, 2 Greek)

    • 99 scientific papers

    • Participation in 158 scientific conferences, workshops, and seminars—highlighting strong engagement with the research community.

⚠️ Areas for Improvement:

  1. Global Visibility
    While research quality is high, international recognition could be improved by targeting higher-impact journals and expanding collaborations outside Greece.

  2. Grants and Funding Leadership
    CV does not specify involvement in research grant acquisition or project funding management—which are often critical metrics in high-level research awards.

  3. Innovation and Patents
    There is no mention of patents, technological innovation, or industry partnerships, which could further enhance her scientific portfolio.

  4. Broader Publication Scope
    Expanding beyond COVID-19-related studies to publish more widely in hematologic and molecular diagnostics would strengthen her long-term research narrative.

🎓 Education:

Dr. Tsiatsiou holds a solid educational background in medicine and public health. She completed her M.D. at the Aristotle University of Thessaloniki (1988–1995), followed by rural service and specialization in Medical Biopathology at Theageneio Anticancer Hospital, obtaining her board certification in 2002. She pursued a Master’s in Health Services Management (2005–2008) at the Hellenic Open University, focusing on blood donor psychology. She furthered her expertise with a Master’s in Public Health at the National School of Public Health, where she studied foodborne infections. Additionally, she obtained a Master’s in Biomedical Sciences with a concentration in Diagnosis and Therapy, focusing on genetic mutations like FV Leiden. Her academic trajectory reflects a deep interdisciplinary approach—combining clinical knowledge, health systems, and research.

🏥 Experience:

Dr. Tsiatsiou’s clinical career spans more than 20 years, primarily within Greece’s National Health System. From 2003 to 2020, she served in various microbiology labs, refining her diagnostic skills. Since July 2011, she has worked in the Hematology Section at AHEPA University Hospital, leading the unit since 2018. Her expertise includes hemostasis, hemoglobinopathies, and molecular testing, and she has been instrumental in staff training and lab management. She led the hemostasis lab during the COVID-19 pandemic, ensuring continuity and quality of diagnostics under pressure. Her dedication to resident education in both Medical Biopathology and General Medicine has made her a respected mentor. Dr. Tsiatsiou’s leadership has elevated the lab’s scientific output, and her involvement in over 150 conferences showcases her engagement with ongoing medical developments.

🔬 Research Focus:

Dr. Tsiatsiou’s research is centered on hematology diagnostics, hemostasis disorders, and molecular markers in infectious diseases. Her most recent work investigates endothelial damage and angiopoietin levels as predictors in COVID-19 patients during the Delta and Omicron waves. This research bridges laboratory medicine with clinical outcomes, offering vital insights into disease severity and prognostics. She also explores genetic predispositions, such as FV Leiden mutations, in thrombotic risk profiling. Her postgraduate theses and training in PCR and molecular hematology underscore her commitment to translational science. With 6 peer-reviewed publications and 99 scientific papers, her academic output is diverse and impactful. Dr. Tsiatsiou’s multidimensional research contributes not only to hematology but also to public health and epidemiology, making her work highly relevant in modern medicine and worthy of recognition.

📚 Publications Top Notes:

  1. 📄 Biomarkers of Endothelial Damage and Disease Severity in COVID-19 Patients, Current Issues in Molecular Biology, 2025

  2. 📄 Angiopoietins as Predictor Indexes in COVID-19 Patients in Delta and Omicron Waves, Current Issues in Molecular Biology, 2024

  3. 📄 Thesis: Trends, Attitudes, and Motivations of Blood Donors and Non-Donors – Hellenic Open University

  4. 📄 Thesis: Foodborne Infections in Urban and Rural Populations of Central Macedonia – National School of Public Health

  5. 📄 Thesis: Prevalence of FV Leiden Mutation in a Tertiary Hospital – Democritus University of Thrace & IHU

  6. 📄 Additional 99 scientific papers and 158 participations in academic events

🧾 Conclusion:

Dr. Panagiota Tsiatsiou is a highly qualified and impactful researcher with significant contributions in hematology, molecular diagnostics, and public health. Her recent publications in Current Issues in Molecular Biology show scientific depth and relevance, especially regarding the clinical progression of COVID-19. She is an excellent candidate for a national or institutional Best Researcher Award, particularly in medical diagnostics and laboratory medicine.

Haydee Dabritz | Infant botulism | Best Researcher Award

Published on by Cell Biologist

Ms. Haydee Dabritz | Infant botulism | Best Researcher Award

Ms. Haydee Dabritz, Calif Dept of Public Health, Infant Botulism Treatment & Prevention Program, United States

Dr. Haydee A. Dabritz is a dedicated epidemiologist specializing in infectious diseases, with a focus on zoonotic pathogens and public health. She currently serves as a Molecular Epidemiology Project Specialist in the Infant Botulism Treatment and Prevention Program at the California Department of Public Health. Her career spans both field and laboratory research, encompassing studies on Toxoplasma gondii transmission through domestic and wild animals and its impact on marine and human health. Her collaborative work has contributed significantly to understanding environmental contamination and zoonotic transmission routes. Dr. Dabritz has authored numerous peer-reviewed publications, presented at international conferences, and has been recognized with multiple fellowships and research awards. Passionate about One Health, she seamlessly integrates epidemiology, microbiology, and wildlife ecology in her work, bridging the gap between human, animal, and environmental health. Her contributions make her a strong contender for the Best Researcher Award.

Publication Profile: 

Scopus

Orcid

✅ Strengths for the Award:

  1. Interdisciplinary Expertise: Dr. Dabritz’s background spans microbiology, epidemiology, veterinary science, and environmental health. Her work reflects a strong One Health approach.

  2. Robust Research Portfolio: She has published extensively in high-impact journals on Toxoplasma gondii, zoonotic diseases, and more recently, infant botulism.

  3. Real-World Impact: Her research has implications for wildlife conservation, water quality, zoonotic transmission, and infant health, demonstrating both academic rigor and public health relevance.

  4. Collaborative and Global Perspective: Dr. Dabritz has worked with multidisciplinary teams, contributed to international research efforts, and presented her findings globally (e.g., ICOPA in Scotland).

  5. Governmental and Surveillance Experience: Her role at the California Department of Public Health reflects an active contribution to ongoing epidemiologic surveillance and response, particularly regarding infant botulism.

  6. Recognition by Peers: Fellowships (Morris Animal Foundation, Cal-EIS) and awards (Best Poster at Anaerobe Conference) showcase peer recognition of her scientific excellence.

🛠️ Areas for Improvement:

  1. Public Science Communication: While Dr. Dabritz excels academically, expanding her public outreach (e.g., through media, public policy briefs, or webinars) could amplify the impact of her research.

  2. Leadership in Multi-Center Studies: Leading large-scale, multi-institutional studies or securing major research grants could further solidify her status as a principal investigator on a national or international level.

  3. Mentorship and Teaching: Additional information on mentoring young researchers or teaching would enhance the picture of her academic leadership.

🎓 Education:

Dr. Dabritz earned her Ph.D. in Epidemiology from the University of California, Davis in 2006, concentrating on infectious diseases. Her dissertation focused on the epidemiology of Toxoplasma gondii in cats and rodents around the Morro Bay area of California—an innovative study bridging environmental science, veterinary medicine, and human health. This work laid the foundation for her future research in zoonotic diseases and environmental contamination. She previously completed her undergraduate education with a Bachelor of Science in Microbiology, graduating Magna Cum Laude from the University of Wisconsin, La Crosse, in 2002. Her academic background combines a robust understanding of microbial science with advanced epidemiological methodologies, which she has applied to both wildlife and human health concerns. Dr. Dabritz’s education has uniquely positioned her to address complex public health issues through an interdisciplinary lens, blending fieldwork, laboratory analysis, and epidemiologic modeling to answer pressing infectious disease questions.

🧪 Experience:

Since February 2021, Dr. Dabritz has served as a Molecular Epidemiology Project Specialist at the California Department of Public Health, focusing on infant botulism. Her work includes patient recruitment for a twin study, manuscript preparation, surveillance, and database management. She has extensive experience in interviewing case parents and supporting national and international surveillance efforts. Previously, she held the Cal-EIS fellowship at Yolo County, where she strengthened her expertise in applied epidemiology. Her prior work includes extensive research on Toxoplasma gondii in coastal California, where she led field studies on free-roaming cats and wild rodents, and contributed to the understanding of environmental transmission pathways. Dr. Dabritz’s career combines hands-on field research, laboratory analysis, public health surveillance, and epidemiologic investigation, showcasing a rare combination of technical knowledge and practical implementation in real-world public health settings.

🏅 Awards and Honors:

Dr. Dabritz has received multiple prestigious honors throughout her academic and professional career. In 2005, she was named a Morris Animal Foundation Fellow for her work on zoonotic diseases. In 2006, she was selected for the Cal-EIS Fellowship at Yolo County, one of California’s most competitive applied epidemiology training programs. Her impactful poster presentation at the 2012 Anaerobe Conference in San Francisco earned her the award for Best Poster, recognizing her communication skills and excellence in scientific research. These accolades reflect her deep commitment to public health, scientific innovation, and interdisciplinary research. Dr. Dabritz’s consistent recognition by peers and professional bodies affirms her status as a leading epidemiologist with notable contributions to both the scientific community and public health infrastructure. Her ability to produce relevant, evidence-based insights in the field of infectious disease epidemiology makes her an ideal candidate for the Best Researcher Award.

🔬 Research Focus:

Dr. Dabritz’s research primarily focuses on infectious disease epidemiology, with a strong emphasis on zoonotic diseases and environmental transmission pathways. Her early work centered on Toxoplasma gondii in domestic and wild animals, investigating how terrestrial contamination affects marine ecosystems and public health. More recently, her research has shifted to infant botulism, where she plays a critical role in understanding disease incidence, fecal excretion duration, and familial patterns through twin studies. Her contributions extend across molecular diagnostics, surveillance systems, and environmental risk assessments. By leveraging One Health principles, she addresses the intersections of animal, human, and environmental health, working to inform public health policy and disease prevention strategies. Dr. Dabritz integrates robust field data with laboratory and statistical analysis to investigate disease dynamics, improve outbreak response, and guide evidence-based interventions, making her research both globally relevant and locally impactful.

📚 Publications Top Notes:

  1. 📘 Transmission of Toxoplasma: clues from sea otters as sentinels – Int J Epidemiol, 2005

  2. 🐱 Outdoor fecal deposition by cats and public attitudes – JAVMA, 2006

  3. 🧪 Evaluation of two Toxoplasma gondii serologic tests in cats – J Parasitol, 2007

  4. 🐭 Ectoparasite diversity and vector-borne disease in rodents – J Med Entomol, 2007

  5. 🧬 Experimental infection of Peromyscus californicus with T. gondii – J Parasitol, 2007

  6. 🦭 Antimicrobial-resistant bacteria in elephant seals – Public Health Rep, 2008

  7. 🧫 Detection of T. gondii oocysts in cat feces and environmental burden – JAVMA, 2007

  8. 🐀 Risk factors for T. gondii in wild rodents in California – J Parasitol, 2008

  9. 🐚 Type X T. gondii in wild mussel and terrestrial mammals – Int J Parasitol, 2008

  10. 🦝 Prevalence of parasitic infections in opossums – J Parasitol, 2008

🧾 Conclusion:

Dr. Haydee A. Dabritz is a highly qualified, deeply committed researcher whose contributions to the fields of infectious disease epidemiology, zoonotic transmission, and infant health are both extensive and impactful. Her ability to translate scientific inquiry into actionable public health practices, combined with her publication record and recognized expertise, makes her an exceptional candidate for the Best Researcher Award. Her work exemplifies excellence in interdisciplinary research and public health relevance, aligning perfectly with the goals of this prestigious honor.

Gary Chan | Host-Pathogen Interactions | Best Researcher Award

Published on by Cell Biologist

Dr. Gary Chan | Host-Pathogen Interactions | Best Researcher Award

Dr. Gary Chan , SUNY Upstate Medical University , United States

Dr. Gary Ching-Tao Chan is a distinguished professor in the Department of Microbiology and Immunology at SUNY Upstate Medical University, Syracuse, NY. He completed his Ph.D. in Immunology at the University of Alberta, Canada, under the supervision of Dr. Larry J. Guilbert. Dr. Chan’s research expertise lies in viral immunology, particularly in human cytomegalovirus (HCMV) and dengue virus (DENV). He has a robust research portfolio with numerous contributions to the field, focusing on viral-host interactions and immune modulation. His work has led to groundbreaking discoveries in HCMV pathogenesis, including viral modulation of autophagy and cell signaling pathways. Dr. Chan has held academic appointments at prestigious institutions, including Louisiana State University Health Science Center, where he contributed significantly to advancing viral immunology. His commitment to research excellence is reflected in his impactful publications and active grant support.

Publication Profile: 

Orcid

Strengths for the Award:

  1. Prolific Research Contributions: Dr. Gary Chan has made significant contributions to the field of microbiology, particularly in the understanding of human cytomegalovirus (HCMV) and its complex interactions with the immune system. His work has been consistently published in top-tier peer-reviewed journals such as Journal of Virology, Antiviral Research, and mBio, highlighting his influence in virology.

  2. Innovative and High-Impact Research: Dr. Chan’s research addresses fundamental aspects of viral pathogenesis, focusing on viral-host interactions, immune modulation, and viral replication. His innovative exploration into the molecular mechanisms of HCMV, such as the modulation of mTORC1 and the role of host transcription factors like HSF1, is groundbreaking and provides valuable insights for potential therapeutic strategies. His studies have also demonstrated significant contributions in understanding how viruses, including HCMV and Dengue virus, alter host cell signaling pathways, making his work crucial in antiviral research.

  3. Successful Grant Support: Dr. Chan has received substantial funding for his research, including multiple NIH R01 grants. His current projects, such as targeting the nuclear HSF1 for anti-HCMV strategies, are promising avenues for the development of novel antiviral therapies, further solidifying his standing as a leading researcher in his field.

  4. Recognition by Peers and Journals: His work has been widely recognized by peers in the field, as evidenced by the Journal of Virology Editor’s Pick in 2024 and the Journal of Virology Spotlight Article of Significant Interest in 2020. These accolades underline the impact and relevance of his research.

  5. Mentorship and Academic Leadership: As a Professor at SUNY Upstate Medical University, Dr. Chan contributes significantly to the academic and professional development of students and colleagues alike. His role in shaping the next generation of researchers, combined with his leadership in the field, highlights his commitment to advancing science.

Areas for Improvement:

  1. Broader Impact Across Other Virus Families: While Dr. Chan’s research on HCMV is groundbreaking, exploring the broader spectrum of viral infections, including RNA viruses like SARS-CoV-2, could expand his impact across viral disease research. By diversifying his focus, he could address other significant public health threats, further enhancing the breadth of his research.

  2. Increased Interdisciplinary Collaboration: Although Dr. Chan has successfully collaborated with various experts in the field of virology, fostering interdisciplinary collaborations with researchers from fields such as bioinformatics, computational biology, and structural biology could accelerate the development of novel antiviral therapies and improve the understanding of viral mechanisms.

  3. Public Engagement and Communication: Dr. Chan’s impactful research is highly technical, and while it has contributed to the scientific community, increased efforts in communicating his findings to the broader public could help in promoting awareness of viral infections and their treatment. Public engagement through media, outreach programs, or collaborative projects with health organizations could amplify his work’s societal impact.

Education:

Dr. Gary Chan earned his Ph.D. in Immunology from the University of Alberta, Edmonton, Canada, from 1999 to 2005. His doctoral research focused on “Human cytomegalovirus-induced trophoblast apoptosis,” under the mentorship of Dr. Larry J. Guilbert in the Department of Medical Microbiology and Immunology. Following his Ph.D., Dr. Chan pursued postdoctoral training at Louisiana State University Health Science Center (2006–2011) in the Department of Microbiology and Immunology. Under the guidance of Dr. Andrew Yurochko, his postdoctoral research expanded his expertise in virology and immune modulation. Dr. Chan’s extensive academic background, coupled with his training in cutting-edge viral immunology, has laid the foundation for his pioneering work on viral-host interactions, particularly with human cytomegalovirus (HCMV), contributing to novel therapeutic strategies.

Experience:

Dr. Gary Chan is a Professor at the Department of Microbiology and Immunology at SUNY Upstate Medical University, a role he has held since 2023. Prior to this, he was an Associate Professor at the same department from 2018 to 2023. Dr. Chan has a wealth of experience in virology and immunology, with a focus on human cytomegalovirus (HCMV) and dengue virus (DENV). He has been instrumental in advancing research on the molecular mechanisms of viral infections and their impact on the host immune system. Dr. Chan’s academic journey includes several years of postdoctoral training at Louisiana State University, where he contributed to significant findings in viral replication and immune responses. With a comprehensive background in molecular virology, cell biology, and immunology, Dr. Chan is recognized for his expertise in viral pathogenesis and therapeutic research.

Awards and Honors:

Dr. Gary Chan has received numerous prestigious awards and recognitions for his research excellence. In 2024, his publication, Human cytomegalovirus modulates mTORC1 to redirect protein translation within quiescently infected monocytes, was selected as an Editor’s Pick by the Journal of Virology. Additionally, his article on HCMV-induced autophagy preventing necroptosis of infected monocytes was featured as a Spotlight Article of Significant Interest in 2020. His innovative research has earned him continuous recognition within the virology community, including numerous peer-reviewed publications. Dr. Chan’s research contributions have also attracted substantial NIH grant support, including an R01 from the NIAID, to explore novel anti-HCMV strategies targeting nuclear HSF1. His scholarly achievements, including the successful funding of multi-year research projects, underscore his dedication to advancing our understanding of viral diseases and their immune modulation.

Research Focus:

Dr. Gary Chan’s research primarily focuses on viral immunology, specifically human cytomegalovirus (HCMV) and dengue virus (DENV). His work explores how these viruses manipulate host cellular processes, such as signaling pathways and immune responses, to promote viral replication and persistence. One of his major research areas is investigating the interactions between HCMV and monocytes, particularly how the virus modulates autophagy and apoptosis to avoid immune detection and promote its survival. Additionally, Dr. Chan’s research delves into the role of host transcription factors, such as HSF1, in regulating viral replication. His innovative work also involves creating bioswitches through protein and DNA engineering to combat HCMV. Through these projects, Dr. Chan aims to identify novel therapeutic targets to limit viral infections and improve antiviral strategies. His work is pivotal in advancing the understanding of how viral infections impact the host immune system and contribute to disease pathogenesis.

Publications Top Notes:

  1. Targeting HSF1 prevents HCMV replication 🦠

  2. DENV infection induces differential immunotranscriptomic profiles 🦟

  3. B cell receptor enhancement of dengue virus infection 🧬

  4. Virion-associated US28 modulates Akt activity in monocytes 💉

  5. The harms of promoting the leak lab hypothesis for SARS-CoV-2 🧫

  6. HCMV modulates mTORC1 in infected monocytes 💪

  7. Virology – The path forward 🔬

  8. Inhibition of SIRT2 promotes HCMV-infected monocyte death ⚔️

  9. Virology under the Microscope – A call for rational discourse 📚

  10. Modulation of host cell signaling in HCMV latency 🧪

Conclusion:

Dr. Gary Ching-Tao Chan is highly deserving of the Best Researcher Award due to his outstanding contributions to the field of virology, particularly in the area of human cytomegalovirus and its interaction with the immune system. His innovative research has shaped the understanding of viral pathogenesis, leading to potential therapeutic breakthroughs. With significant funding, prestigious recognition, and a strong academic presence, Dr. Chan continues to push the boundaries of scientific knowledge. While there are opportunities for expansion into other viral research areas and greater public outreach, his accomplishments make him a leading figure in microbiology and an excellent candidate for this award.

Huiying Fan | Host-Pathogen Interactions | Best Researcher Award

Published on by Cell Biologist

Dr. Huiying Fan | Host-Pathogen Interactions | Best Researcher Award

Dr. Huiying Fan , College of Veterinary Medicine, South China Agricultural University , China

Dr. Huiying Fan is a distinguished professor and doctoral supervisor at the College of Veterinary Medicine, South China Agricultural University, specializing in veterinary virology and immunology. As a core member of the Key Laboratory for Veterinary Vaccine Development, his expertise includes creating genetically engineered vaccines for animal viruses. Dr. Fan has published over 40 research papers in leading journals, including Journal of Virology and Emerging Microbes & Infections, and holds 11 invention patents. His career has been marked by significant contributions to animal virus research and vaccine development, with extensive involvement in national research programs. He has been recognized with several provincial and ministerial-level awards and is actively involved in scientific development and industry collaboration in China.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Huiying Fan has demonstrated exceptional contributions to the field of veterinary virology and immunology, particularly in the development of vaccines for animal viruses. He is a recognized leader in the creation of genetically engineered vaccines, with over 40 SCI papers published in high-impact journals such as Journal of Virology, Emerging Microbes & Infection, and Vaccines. His involvement in groundbreaking research on the pathogenic mechanisms of viruses like avian influenza, porcine epidemic diarrhea, and African swine fever underscores his expertise. Furthermore, Dr. Fan has been granted 11 invention patents and is an influential figure in national research programs, such as the National Key Research and Development Program. His leadership as a professor and mentor, coupled with his ongoing innovations in virus detection and vaccine development, showcases his remarkable impact in the field.

Areas for Improvement:

While Dr. Fan’s scientific research has been groundbreaking, expanding his focus on broader global collaborations could enhance the scope of his work. In particular, his work could benefit from incorporating more interdisciplinary approaches, combining cutting-edge technologies such as artificial intelligence or big data analytics, which are becoming increasingly crucial in disease surveillance and vaccine development. Moreover, his research could further address the application of his vaccine technologies in low-resource settings, to maximize global health impact. Engaging more actively in science communication could also help translate his findings into policies or programs that benefit larger populations, both within China and internationally.

Education:

Dr. Fan completed his Ph.D. in Preventive Veterinary Medicine at the College of Veterinary Medicine, Huazhong Agricultural University, in June 2007. During his doctoral research, he focused on the study of veterinary diseases and virus-host interactions, laying a strong foundation for his future work in vaccine development. His commitment to advancing veterinary science continued through postdoctoral training, followed by his establishment as a professor at South China Agricultural University. His education reflects his dedication to merging academic research with practical applications for the improvement of animal health and disease prevention.

Experience:

Dr. Fan’s career began in 2007 as a professor at South China Agricultural University, where he became a leading figure in veterinary medicine. He has also contributed significantly to international research, evidenced by his six-month research visit to City University of Hong Kong in 2016. As a core member of several high-impact research initiatives, including the National Key Research and Development Program, he has played a vital role in advancing veterinary virology and vaccine development. Dr. Fan’s extensive expertise has led to collaborations across national projects and scientific endeavors, particularly in the realm of infectious diseases and immune responses in animals.

Awards and Honors:

Dr. Fan has received multiple prestigious awards throughout his career, including 8 provincial and ministerial-level honors. Notably, he was named a “Pearl River Science and Technology Star” in Guangzhou and recognized as a “Science and Technology Commissioner” by the People’s Government of Guangdong Province. His contributions to veterinary science have garnered recognition both within China and internationally, highlighting his commitment to scientific excellence and industry collaboration. These accolades underscore his leadership in veterinary vaccine research and his influence on public health initiatives concerning animal diseases.

Research Focus:

Dr. Fan’s primary research interests lie in the molecular design of genetically engineered vaccines for animal viruses, including those affecting poultry and swine. His studies explore the immune mechanisms and pathogenesis of viruses such as avian influenza and porcine viral diarrhea. In addition to his work on vaccine development, he investigates the use of innovative techniques, including CRISPR/Cas12a and proteomics, to better understand virus-host interactions and to improve diagnostic and therapeutic strategies for animal diseases. His focus on veterinary virology aims to enhance both animal and public health outcomes.

Publication Top Notes:

  1. “A single immunization with H5N1 virus-like particle vaccine protects chickens against divergent H5N1 influenza viruses” 🐔🦠
  2. “Influenza H7N9 Virus Hemagglutinin with T169A Mutation Possesses Enhanced Thermostability” 🦠❄️
  3. “Immune Escape Mechanism and Vaccine Research Progress of African Swine Fever Virus” 🐖🦠
  4. “Supplementation of H7N9 Virus-Like Particle Vaccine With Recombinant Epitope Antigen Confers Full Protection” 🦠💉
  5. “PEDV infection affects the expression of polyamine-related genes inhibiting viral proliferation” 🐖🧬
  6. “Proteome Analysis in PAM Cells Reveals That African Swine Fever Virus Can Regulate Intracellular Polyamines” 🧬🔬
  7. “CRISPR/Cas12a Technology Combined with Immunochromatographic Strips for Portable Detection of ASF Virus” 🧬🦠
  8. “Quantitative Proteomics Reveals Changes in Vero Cells in Response to Porcine Epidemic Diarrhea Virus” 🐖🔬
  9. “Coimmunization with recombinant epitope-expressing baculovirus enhances protective effects of H5N1 vaccine” 💉🦠
  10. “Either fadD1 or fadD2, Which Encode acyl-CoA Synthetase, Is Essential for the Survival of Haemophilus parasuis SC096” 🦠🔬
  11. “Two Glycosyltransferase Genes of Haemophilus parasuis SC096 Implicated in Lipooligosaccharide Biosynthesis” 🧬🦠
  12. “Recombinant baculovirus vaccine containing multiple M2e and adjuvant LT induces T cell-dependent protection against H5N1” 💉🦠
  13. “BacMam virus-based surface display of IBV S1 glycoprotein confers strong protection against virulent IBV challenge” 🐔🦠
  14. “Quantitative Proteomics by Amino Acid Labeling in Foot-and-Mouth Disease Virus-Infected Cells” 🐄🧬
  15. “Quantitative proteomics using SILAC reveals protein and pathway regulation in porcine circovirus type 2 infected PK-15 cells” 🐖🧬

Conclusion:

Dr. Huiying Fan is undoubtedly a strong contender for the Research for Best Researcher Award, given his outstanding contributions to animal virus research, innovative vaccine design, and leadership in national research initiatives. His extensive publication record, patent portfolio, and recognition through prestigious awards highlight his scientific excellence. Although expanding his collaborative network and exploring interdisciplinary methodologies could elevate his impact further, Dr. Fan’s work has already had a profound effect on veterinary medicine and public health, making him a well-deserved nominee for this award.